# MyGlomCon — GlomCon Member Portal > Global network for nephrologists to advance glomerular disease care. (iPhone/iPad app by Glomerular Disease Study and Trial Consortium.) - Source: https://appshunter.io/ios/app/myglomcon/id6496679630 (this page in markdown: same URL + `.md`) - Developer: [Glomerular Disease Study and Trial Consortium](https://appshunter.io/developer/1649288273) - Category: Education - Price: Free with in-app purchases - Rating: 5.00/5 from 1 App Store ratings - Age rating: 17+ - Requires: iOS 15.1 · 79 MB - Languages: American English - Released: 2024-07-08 - Data updated: 2026-09-01 - Monetization: free - User reviews in markdown: https://appshunter.io/ios/app/myglomcon/id6496679630/reviews.md ## What is MyGlomCon? Our goal is to enable our global network of nephrologists and nephropathologists to come together and define the future of glomerular disease care. GlomCon is a nonprofit, charitable 501c(3) organization, registered in the U.S. Every GlomCon Lecture GlomCon Seminars started in 2016 as virtual multidisciplinary seminars that included case discussions and lectures by world-renowned experts. Due to the outstanding learning experience provided by the exceptional faculty and speakers, GlomCon Seminars grew from a small virtual community of nephrologists in Boston to a weekly event with global participants from over 130 countries. This App provides access to the entire archive and more. Professional Forum A closed corner for healthcare professionals to exchange experience, and discuss the latest evidence, clinical trials, and diagnostic or treatment opportunities. Courses and Fellowship This App also provides access to KPCP and GlomCon Fellowship content to those who have successfully enrolled in those courses. ## Key features - Glomerular disease care advancement - Archive of lectures and seminars - Professional discussion forum - Access to fellowship content - Global network connectivity ## Pricing and in-app purchases Base price: Free. **One-time purchases** | Purchase | Price | Type | | --- | --- | --- | | 2024 Kidney Pathology Cert | $690.00 | one-time | ## Frequently asked questions about MyGlomCon ### What is the learning methodology used by MyGlomCon? MyGlomCon provides access to virtual multidisciplinary seminars, lectures by world-renowned experts, and case discussions. This approach focuses on sharing knowledge and clinical experiences among global participants. ### How does MyGlomCon track user progress? The app provides access to courses and fellowship content for enrolled users, suggesting progress tracking is tied to course completion. Specific progress metrics are not detailed in the provided information. ### Does MyGlomCon offer certifications? While the app provides access to fellowship content, it does not explicitly state whether certifications are offered. Users should refer to specific course enrollment details for certification information. ### What is the update frequency for MyGlomCon? The app was last updated on 2026-05-09, indicating active development. While specific update frequency isn't listed, the recent update suggests ongoing maintenance and feature additions. ### What devices support MyGlomCon? MyGlomCon is available on iPhone, iPad, and iPod. This ensures accessibility for a wide range of Apple mobile device users. ### Is MyGlomCon suitable for younger users? MyGlomCon has an age rating of 17+, indicating it is intended for adult users. The content focuses on advanced medical topics relevant to healthcare professionals. ### What do users like most about MyGlomCon? With a 5.0-star rating from one review, user sentiment appears highly positive. Users likely appreciate the access to expert lectures and the professional networking opportunities. ### Does MyGlomCon have ads? No, MyGlomCon does not contain advertisements. The app is free to download and use without any ad interruptions. ## Version history (last 5 releases) ### 2.16.0 — 2026-08-24 What’s New? - Bug fixes and improvements. ### 2.14.1 — 2026-08-01 What’s New? - Bug fixes and improvements. ### 2.13.1 — 2026-06-20 What’s New? - Bug fixes and improvements. ### 2.12.0 — 2026-06-09 What’s New? - Bug fixes and improvements. ### 2.10.2 — 2026-05-09 What’s New? - Bug fixes and improvements. ## Apps similar to MyGlomCon | App | Rating | Price | Category | | --- | --- | --- | --- | | [Boards (ABIM & ABFM)](https://appshunter.io/ios/app/boards-abim-and-abfm/id984706854) | 4.6 (270) | Free | Education | | [Thalamus](https://appshunter.io/ios/app/thalamus/id918406174) | 3.8 (477) | Free | Education | | [MedSafeAI: AI Doctor Assistant](https://appshunter.io/ios/app/medsafeai-ai-doctor-assistant/id6738038008) | 4.8 (646) | Free | Education | | [Dr.Oracle AI Medical Assistant](https://appshunter.io/ios/app/droracle-ai-medical-assistant/id6473809057) | 4.7 (1,041) | Free | Education | | [NKF Meetings](https://appshunter.io/ios/app/nkf-meetings/id1631549825) | 3.5 (2) | Free | Education | | [Nephrology Conference](https://appshunter.io/ios/app/nephrology-conference/id6523414074) | — | Free | Education | ## More apps by Glomerular Disease Study and Trial Consortium - [GlomCon Network](https://appshunter.io/ios/app/glomcon-network/id1662973920) - [GlomPedia](https://appshunter.io/ios/app/glompedia/id6578423847) - [NephroVax](https://appshunter.io/ios/app/nephrovax/id6757649641) - [GlomCon Hawaii](https://appshunter.io/ios/app/glomcon-hawaii/id6791670049) All apps by Glomerular Disease Study and Trial Consortium: https://appshunter.io/developer/1649288273 ## Related topics [nephropath](https://appshunter.io/ios/topics/nephropath) · [nephrovax](https://appshunter.io/ios/topics/nephrovax) · [nephrology](https://appshunter.io/ios/topics/nephrology) · [pnrconsortium](https://appshunter.io/ios/topics/pnrconsortium) · [american society of nephrology](https://appshunter.io/ios/topics/american-society-of-nephrology) --- *Data collected daily from the US App Store and indexed by [AppsHunter](https://appshunter.io/). User reviews are verbatim App Store reviews. Ratings, prices and chart positions refresh continuously; this snapshot is from 2026-09-01.*